• A Brighter Future: Exploring the Role of Brentuximab vedotin in Pediatric Hodgkin’s Lymphoma

  • May 15 2024
  • Length: 26 mins
  • Podcast
A Brighter Future: Exploring the Role of Brentuximab vedotin in Pediatric Hodgkin’s Lymphoma  By  cover art

A Brighter Future: Exploring the Role of Brentuximab vedotin in Pediatric Hodgkin’s Lymphoma

  • Summary

  • Taylor Gullickson, PharmD explores the role of brentuximab vedotin in pediatric Hodgkin’s lymphoma.

    For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.

    You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on X at @MayoMedE

    Show more Show less

What listeners say about A Brighter Future: Exploring the Role of Brentuximab vedotin in Pediatric Hodgkin’s Lymphoma

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.